Showing results (1-10 of 23) with videos related to
Sort By:
Pageof 3
Cells|March 25, 2022
SWI/SNF Antagonism of PRC2 Mediates Estrogen-Induced Progesterone Receptor ExpressionMike R Wilson, Jake J Reske, Julie Koeman, et al.Plos One|February 26, 2015
Human biosample authentication using the high-throughput, cost-effective SNPtrace(TM) systemMay M Y Liang-Chu, Mamie Yu, Peter M Haverty, et al.Proceedings of the National Academy of Sciences of the United States of America|May 23, 2007
Chromosome instability, chromosome transcriptome, and clonal evolution of tumor cell populationsChongFeng Gao, Kyle Furge, Julie Koeman, et al.Cancer Research|April 6, 2007
Detection of DNA copy number changes and oncogenic signaling abnormalities from gene expression data reveals MYC activation in high-grade papillary renal cell carcinomaKyle A Furge, Jindong Chen, Julie Koeman, et al.Proceedings of the National Academy of Sciences of the United States of America|November 24, 2004
Activating Met mutations produce unique tumor profiles in mice with selective duplication of the mutant alleleCarrie Graveel, Yanli Su, Julie Koeman, et al.Scientific Reports|January 24, 2026
Integrated safety and microbiota profiling of fulvic acid formulations across in vitro and in vivo modelsAleksandra Szwed-Georgiou, Przemysław Płociński, Marcin Włodarczyk, et al.Proceedings of the National Academy of Sciences of the United States of America|December 9, 2016
Chromosome instability drives phenotypic switching to metastasisChongFeng Gao, Yanli Su, Julie Koeman, et al.Pigment Cell & Melanoma Research|May 9, 2009
Met amplification and tumor progression in Cdkn2a-deficient melanocytesMatthew W Vanbrocklin, James P Robinson, Todd Whitwam, et al.Proceedings of the National Academy of Sciences of the United States of America|July 19, 2005
Proliferation and invasion: plasticity in tumor cellsChong-Feng Gao, Qian Xie, Yan-Li Su, et al.Proceedings of the National Academy of Sciences of the United States of America|January 12, 2011
Chromosomal amplification of leucine-rich repeat kinase-2 (LRRK2) is required for oncogenic MET signaling in papillary renal and thyroid carcinomasBrendan D Looyenga, Kyle A Furge, Karl J Dykema, et al.Pageof 3